期刊文献+

老年性肝门部胆管癌的临床分析(附97例报告)

Clinical Analysis in Elderly Patients with Hilar Bileduct Carcinoma(97 cases)
暂未订购
导出
摘要 目的 探讨老年性肝门部胆管癌的诊断和治疗。方法 回顾性分析从1995年1月~2005年12月收治的97例老年性肝门部胆管癌患者的临床资料和随访资料。结果 97例中,28例行根治性切除术,25例行姑息性切除术,30例行介入治疗术,主要为胆道引流加动脉栓塞化疗,其余的14例既未行外科亦未行介入治疗(包括10例仅行胆道引流,4例仅行内科治疗)。根切组、姑切组及介入组的1、2、3年生存率分别为82.4%、64.3%、57.4%,80.0%、50.0%、32.0%和50.0%、30.0%、10%,非手术及介入治疗组无1例存活12个月以上。术后并发症率为31.9%(31/97),术后病死率为1.0%(1/97)。结论 外科治疗是老年性肝门部胆管癌的主要治疗方法,而介入治疗有时亦是一种较好选择,重要的是认真评估患者病情,选择合适治疗方法和重视围手术期处理。 Objectire To investigate the diagnosis and treatment of hilar bileduct carcinoma in elderly patients. Methods The clinical data of 97 elderly patients who suffered from hilar bileduct carcinoma were retrospectively analyzed. Result Amony the 97 cases, 28 patients underwent radical resection, 25 patients underwent palliative resection, 30 patients did interventional radiology treatment (transarterial chemoembolization after biliary drainage), the rest 14 Patients were not treated with surgery or intenventional radiology. The 1,2,3year Survival rate was 82.4%, 64.3%, 57.4% in radical resection group, 80.0%, 50.0%, 32.0%in palliative resection group and 50.0%, 30.0%, 10.0% in interventional treatment group. All the patients in the group without surgery or interventional treatment died within 12 months. The rate of complication gas 31.9% and only one patient died after operation. Conclusion Surgery is the main treatmmt method for hilar bileduct carcinoma in elderly patients, while interventional treatment is also a better choice in some cases.
出处 《国际医药卫生导报》 2007年第12期51-53,共3页 International Medicine and Health Guidance News
关键词 肝门部胆管癌 老年 诊断 外科治疗 介入治疗 Hilar bileduct carcinoma The aged Diagnosis Surgery Interventiond radioeogy
  • 相关文献

参考文献5

二级参考文献41

  • 1汪谦.不能切除的肝门部胆管癌的外科治疗[J].临床外科杂志,2004,12(3):135-136. 被引量:10
  • 2黄志强.肝门部胆管癌的外科治疗[J].中华外科杂志,1990,28:522-526.
  • 3孙占祺.肝门胆管癌的诊断和治疗[J]..第九届全国普通外科学术会议资料汇编[C].无锡,2002.143.
  • 4.[A]..[C].,..
  • 5陈明易 黄志强 陈乐真 等.肝外胆管癌组织中的HBsAg和HCVNS5抗原检测[J].军医进修学院学报,2000,21(2):116-116.
  • 6Nishio H, Kamiya J, Nagino M, et al. Value of percutaneous transhepatie portography before hepateetomy for hilar cholangiocarcinoma [J]. Br J Surg, 1999 ; 86(11) ; 1415.
  • 7Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepateetomy for hilar bile duet carcinomar a preliminary report [J]. Surgery, 1990; 107(5) ; 521.
  • 8Guthrie CM, Haddock G, De Beaux AC, et al. Changing trends in the management of extrahepatic cholangiocarcinoma [J]. Br J Surg, 1993; 80(11) : 1434.
  • 9Nimura Y, Hayakawa N, Kamiya J, et al. Hepatectomy for hilar bile duct cancer [J]. Asian J Surg, 1996; 19(2) : 94.
  • 10Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system[J].Ann Surg, 1998; 228(3) :385.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部